Hanuja (India) Medicines Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 0.28%
- Ebitda
- Net Worth -15.68%
- Total Assets -15.68%
About Hanuja (India) Medicines
Hanuja (India) Medicines Private Limited (HIMPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2018 (Six years and 11 months 11 days old ). Its registered office is in Ahmed Nagar, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akshay Gandhi and Suvarna Gandhi serve as directors at the Company.
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999PN2018PTC175312
- Company No.
175312
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Hanuja (India) Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Gandhi  | Director | 12-Mar-2018 | Current |
| Suvarna Gandhi | Director | 12-Mar-2018 | Current |
Financial Performance of Hanuja (India) Medicines.
Hanuja (India) Medicines Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.28% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hanuja (India) Medicines?
In 2019, Hanuja (India) Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hanuja (India) Medicines?
Unlock and access historical data on people associated with Hanuja (India) Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hanuja (India) Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hanuja (India) Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.